AIM
FLGT icon

Aigen Investment Management’s Fulgent Genetics FLGT Stock Holding History

Aigen Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,410
Closed -$326K – 890
2025
Q2 		$326K Buy
16,410
+3,329
+25% +$64.9K 0.04% 502
2025
Q1 		$221K Buy
13,081
+1,328
+11% +$22.6K 0.04% 604
2024
Q4 		$217K Buy
+11,753
New +$229K 0.04% 587
2023
Q4 		– Sell
-8,971
Closed -$240K – 881
2023
Q3 		$240K Buy
+8,971
New +$306K 0.05% 606

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Aigen Investment Management's FLGT Position: Q3 2025 in Review

Aigen Investment Management sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 16,410 shares — an estimated $326K sold.

Aigen Investment Management first reported a position in FLGT in Q3 2023 and held it in 4 quarters. The position peaked at $326K in Q2 2025. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Aigen Investment Management reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Aigen Investment Management sold 16,410 Fulgent Genetics shares in Q3 2025, an estimated $326K.
  • Aigen Investment Management first reported a position in Fulgent Genetics in Q3 2023 and held it in 4 quarters.
  • Aigen Investment Management's Fulgent Genetics position peaked at $326K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Aigen Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.